🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for HIV/AIDS and Infections

A Study to Evaluate Performance, Usability, and Contrived Result Interpretation of TruPlex HIV/HepB/Syphilis Rapid Test NCT07563309NA3 sites📍 Johannesburg📍 Durban📍 Cape Town bioLytical Laboratories · Tests: TruPlex HIV/HepB/Syphilis Rapid Test The Integrated Female Sexually Transmitted Infection Testing for HIV Epidemic Control Through PrEP (IN-STEP) Study NCT06743204NA1 site📍 Kalisizo Johns Hopkins University · Tests: Self-Reported Risk Screening for PrEP and Diagnostic STI testing, Self-reported risk screening for PrEP and syndromic m… Semaglutide's Efficacy in Achieving Weight Loss for Those With HIV NCT04174755NA1 site📍 Dublin University College Dublin · Tests: Semaglutide Injectable Product, Standard of care A Study to Investigate Pharmacokinetics (PK), Safety, and Tolerability of VH4367310 in Healthy Adult Participants NCT07818915Phase 12 sites📍 Glendale📍 Baltimore ViiV Healthcare · Tests: VH4367310, Placebo Safety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine in People With HIV Who Have a CD4 Count Less Than 300 or Greater Than or Equal to 300 and a Healthy Control Population NCT05580458Phase 1, Phase 21 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… · Tests: Shingrix Immuno-virological Evaluation of Persons Living With HIV (PLWH) NCT05973825NA1 site📍 Ghent University Hospital, Ghent · Tests: Leucapheresis Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India NCT07209917NA4 sites📍 Bangalore📍 Bangalore📍 Bangalore University of California, Irvine · Tests: SAKHI HPV Intervention, Enhanced Standard of Care (SOC+) A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study) NCT07202546Phase 2123 sites📍 Bakersfield📍 Palm Springs📍 West Hollywood ViiV Healthcare · Tests: VH4524184, Emtricitabine (FTC) and tenofovir alafenamide (TAF) Fixed Dose Combination (FDC) tablets, Dolutegravir / Lam… Dolutegravir Pharmacokinetics Among HIV/TB Coinfected Children Receiving Standard and High-dose Rifampicin NCT05069688Phase 11 site📍 Ibadan Brigham and Women's Hospital · Tests: rifampicin A Mobile Gaming App to Improve Adherence to PrEP NCT05762705NA3 sites📍 Boston📍 Jackson📍 Providence Rhode Island Hospital · Tests: Multilevel Gaming Adherence Intervention, Treatment as Usual + Polypharmacy on Healthy Aging in People Living With HIV Over the Age of 75 NCT07388394NA1 site📍 Nice Centre Hospitalier Universitaire de Nice · Tests: interview with advanced practice nurse Platform Trial For Cryptococcal Meningitis (PLATFORM-CM) NCT06666322Phase 2, Phase 32 sites📍 Kampala📍 Mbarara David Boulware · Tests: Standard of care, Oteseconazole - antifungal therapy 1, Turletricin injection - antifungal therapy 2, Turletricin Injec… Development of a Predictive Model for Sexually Transmitted Infections in Individuals Using Pre-Exposure Prophylaxis for HIV in Spain NCT06860945n/a26 sites📍 Almería📍 Cadiz📍 Cartagena Hospital Universitario de Valme · Tests: No Intervention: Observational Cohort Efficacy and Safety of ACC017 Tablets Compared With Dolutegravir Sodium Tablets in Treatment-Naïve Adults With Human Immunodeficiency Virus Type 1 (HIV-1) NCT07711223Phase 1, Phase 21 site📍 Beijing Jiangsu Aidea Pharmaceutical Group Co., Ltd. · Tests: ACC017+FTC/TAF, DTG+FTC/TAF CASCADE 2002: PROTECT Study, "PRObiotics to TrEat Anal preCancer Trial NCT06949800Phase 22 sites📍 San Francisco📍 San Juan University of California, San Francisco · Tests: EXE-346 Probiotic, Placebo, Usual Care High Resolution Anoscopy (HRA) Identifying Challenges to Healthy Aging in Persons With Human Immunodeficiency Virus (HIV) Age 50 and Older NCT05858034NA1 site📍 Winston-Salem Wake Forest University Health Sciences · Tests: Customized activity plan, Customized nutrition plan Study of Autophagy and the Effects of GALIG Gene Products in HIV-1 Infected Patients Who Are Under Antiretroviral Therapy Since Primary-infection, Chronic Phase, or Never Treated. NCT04160455n/a1 site📍 Orléans Centre Hospitalier Régional d'Orléans · Tests: expression of a panel Practice Facilitation as a Strategy to Improve Alcohol Treatment Adoption and Implementation in HIV Care NCT05241990NA3 sites📍 San Diego📍 Boston📍 Chapel Hill Johns Hopkins University · Tests: Practice Facilitation, Alcohol Stepped Care Italian Registry of HIV-1 Infected Patients With Drug-RESistant Virus to Reverse Transcriptase Inhibitors, InteGrasE and Viral Protease. NCT04098315n/a1 site📍 Milan Castagna Antonella · Tests: REGISTER CREATION Evaluation of Long-Acting Injectable (LAI) and Teen Clubs in Adolescents (ATTUNE). NCT06721078NA12 sites📍 Johannesburg📍 Johannesburg📍 Pretoria Africa Health Research Institute · Tests: Peer navigation effectiveness Recurrent Visceral Leishmaniasis in HIV Co-Infection NCT07487350n/a1 site📍 Gonder Institute of Tropical Medicine, Belgium Alcohol Misuse, Gut Microbial Dysbiosis and PrEP Care Continuum: Application and Efficacy of SBIRT Intervention NCT06005298NA1 site📍 Louisville Shirish S Barve · Tests: Screening, Brief Intervention, Referral to Treatment (SBIRT) Impact of Pain From Injectables Antiretroviral Treatments in HIV-1 Patients Based on the Injection Site (Ventrogluteal or Dorsogluteal) and the Use or Non-use of Virtual Reality Headset NCT06834113NA5 sites📍 Orléans📍 La Roche-sur-Yon📍 Le Coudray Centre Hospitalier Régional d'Orléans · Tests: Dorsogluteal intramuscular injection Precision Imaging to Evaluate Kaposi Sarcoma NCT06898203NA2 sites📍 Kisumu📍 Kampala Washington University School of Medicine · Tests: SkinScan3D Influence of Resentment and Forgivingness on Quality of Life in People Living With HIV NCT05660148n/a1 site📍 Amiens Centre Hospitalier Universitaire, Amiens Expanding HOPE Liver NCT07778459n/a2 sites📍 Baltimore📍 New York National Institute of Allergy and Infectious Diseases (NIAI… Evaluation of Safety and Immunogenicity of Ad26.Mos4.HIV and CH505 TF chTrimer Combination in Healthy Adults NCT06205056Phase 11 site📍 Kampala U.S. Army Medical Research and Development Command · Tests: Ad26.Mos4.HIV in CH505 TF chTrimer + ALFQ [Arm 1a], CH505 TF chTrimer + ALFQ [Arm 1a], Placebo [Arm 1a], Ad26.Mos4.HIV … A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062) NCT07266831Phase 2, Phase 355 sites📍 Los Angeles📍 Denver📍 Washington D.C. Merck Sharp & Dohme LLC · Tests: ISL, ULO, BIC/FTC/TAF, Placebo for BIC/FTC/TAF, Placebo to ISL/ULO REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE NCT07476339Phase 410 sites📍 Clearwater📍 Ft. Pierce📍 Jacksonville CAN Community Health · Tests: Bictegravir, emtricitabine, and tenofovir alafenamide Efficacy, Safety, and ToLerability of Switching to A Two-Drug Regimen With DTG/3TC Compared to Maintaining A Three-Drug REgimen With BIC/FTC/TAF or DTG/3TC/ABC in ViroLogically SupprEssed PeopLe Living With HIV After 24 and 48 Weeks of Follow-Up NCT07138144Phase 41 site📍 Mexico City José Antonio Mata Marín · Tests: Standard Medical Therapy, dual therapy
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy